EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 22 / No 10 (Octobre 2006) Med Sci (Paris), 22 10 (2006) 881-886 References
Free Access
Issue
Med Sci (Paris)
Volume 22, Number 10, Octobre 2006
Page(s) 881 - 886
Section Forum
DOI https://doi.org/10.1051/medsci/20062210881
Published online 15 October 2006
  1. Grimes DA, Hubacher D, Nanda K, et al. The good clinical practice guideline : a bronze standard for clinical research. Lancet 2005; 366 : 172–4. [Google Scholar]
  2. Lievre M, Menard J, Bruckert E, et al. Premature discontinuation of clinical trial for reasons not related to efficacy, safety, or feasibility. Br Med J 2001; 322 : 603–5. [Google Scholar]
  3. Psaty BM, Rennie D. Stopping medical research to save money : a broken pact with researchers and patients. JAMA 2003; 289 : 2128–31. [Google Scholar]
  4. Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. Vigor study group. N Engl J Med 2000; 343 : 1520–8. [Google Scholar]
  5. Silverstein F, Simon L, Faich G. Reporting of 6-month versus 12-month data in a clinical trial of Celocoxib. JAMA 2001; 286 : 2398–400. [Google Scholar]
  6. Steinbrook R. Protecting research subjects : the crisis at Johns Hopkins. N Engl J Med 2002; 346 : 716–20. [Google Scholar]
  7. Ray WA, Stein CM. Reform of drug regulation--beyond an independent drug-safety board. N Engl J Med 2006; 354 : 194–201. [Google Scholar]
  8. Brun-Buisson C. Les DSMB. 1. Quel rôle, quelles responsabilités ? Med Sci (Paris) 2005; 21 : 78–82. [Google Scholar]
  9. Brun-Buisson C. Les DSMB. 2.De l’importance d’un DSMB efficace, exemples d’essais cliniques à risque. Med Sci (Paris) 2005; 21 : 187–9. [Google Scholar]
  10. Ioannidis JP. Why most published research findings are false. PLoS Med 2005; 2 : e124. [Google Scholar]
  11. Hampton T. Biomedical journals probe peer review. JAMA 2005; 294 : 2287–8. [Google Scholar]
  12. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1 : 1311–5. [Google Scholar]
  13. Angell M. The truth about the drug companies. New York : Random House, 2004. [Google Scholar]
  14. Daurat V. Les règles de l’AP-HP promoteur. Journal de la DRRC de l’Ile-de-France 2002; 1 : 3.2. [Google Scholar]
  15. Daurat V. Les règles de l’AP-HP promoteur. Lettre de la DRRC de l’Ile-de-France 2002; 2 : 3.3.1. [Google Scholar]
  16. Ménard J. Qui a tué Ellen Roche ? Lettre de la DRRC de l’Ile-de-France 2002; 2 : 3.2. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.